Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Director Dealing

18 Nov 2020 17:52

RNS Number : 7938F
Remote Monitored Systems PLC
18 November 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

18 November 2020

Remote Monitored Systems plc ("RMS" or the "Company")

Director Dealing

The Company has been notified that Paul Ryan, Non-Executive Chairman of the Company, has sold 28,942,970 ordinary shares in the Company.

 

Following this transaction, Paul Ryan holds no shares in the Company. He continues to hold 38,801,756 share options at an exercise price of 1.4p per share.

 

ENQUIRIES:

Remote Monitored Systems plc

Trevor Brown (Executive Director) +41 7941 55384

Paul Ryan (Non-Executive Chairman) +32 475 754 148

 

SP Angel Corporate Finance LLP         +44 20 3470 0470

Nominated Adviser and joint broker        

Stuart Gledhill

Caroline Rowe

 

Peterhouse Capital Limited         +44 20 7469 0930

Joint broker 

Lucy Williams

Duncan Vasey

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Paul Ryan

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Chairman

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Remote Monitored Systems plc

b)

 

LEI

 

213800VR2P5DDQHYZO48

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 0.01 pence each  

 

GB00BFX0ZN92

b)

 

Nature of the transactions

 

Sale of ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

2.9p

 

 

Volume(s)

 

28,942,970

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

Single transaction as in 4 c) above  

e)

 

Dates of the transaction

 

18 November 2020

f)

Place of transaction

AIM

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZMMMNRLGGZM
Date   Source Headline
24th Feb 202111:05 amRNSSecond Price Monitoring Extn
24th Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20211:00 pmRNSUpdate on commissioning and board changes
12th Feb 20212:05 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
12th Feb 20211:12 pmRNSResult of General Meeting
12th Feb 20217:00 amRNSGeneral Meeting – Link for webinar
9th Feb 20215:56 pmRNSShareholders’ Questions and Answers
8th Feb 20211:23 pmRNSExercise of Options
1st Feb 20211:08 pmRNSExercise of Options
1st Feb 20217:00 amRNSCommissioning delayed
29th Jan 20217:00 amRNSTotal Voting Rights
27th Jan 20217:00 amRNSNotice of General Meeting
26th Jan 20217:00 amRNSExercise of Options
25th Jan 20213:29 pmRNSExercise of Options
25th Jan 20217:00 amRNSExercise of Warrants
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 202112:56 pmRNSEN14683 Certification, Commissioning Update
22nd Jan 20217:00 amRNSShare Option Grant update
21st Jan 20219:06 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 20217:00 amRNSBoard appointment,update on mask production and GM
11th Jan 20216:26 pmRNSDirector Dealing
11th Jan 20217:00 amRNSBoard changes
8th Jan 20215:00 pmRNSDirector Option Exercise and Total Voting Rights
8th Jan 20217:00 amRNSDirector Option Exercise and Total Voting Rights
7th Jan 202110:52 amRNSStatement regarding share price movement
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20217:00 amRNSPharm 2 Farm Update
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
31st Dec 202011:51 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSPlanned Board Changes & Warrant Update
29th Dec 20207:00 amRNSPharm 2 Farm Update
23rd Dec 20208:13 amRNSUpdate on Fundraising & response to announcements
18th Dec 202011:05 amRNSSecond Price Monitoring Extn
18th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20209:51 amRNSPlacing to raise £5,000,000 and Issue of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.